Michael Weller

Princess Margaret Cancer Centre (CA)

Research Areas

Discover Papers by Michael Weller

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

173

Publications

2820

Citations

160156

i10-index

1082

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozol...	2005	20758
Effects of radiotherapy with concomitant and adjuv...	2009	7605
<i>MGMT</i> Gene Silencing and Benefit from Temozo...	2005	7001
Effect of Tumor-Treating Fields Plus Maintenance T...	2017	2372
An endogenous tumour-promoting ligand of the human...	2011	1776
EANO guidelines on the diagnosis and treatment of ...	2020	1667
Current state of immunotherapy for glioblastoma	2018	1318
Effect of Nivolumab vs Bevacizumab in Patients Wit...	2020	1314
Type and frequency of IDH1 and IDH2 mutations are ...	2009	1134
Temozolomide chemotherapy alone versus radiotherap...	2012	1094

Publications

1.
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Year: 2005Citations: 20758DOI: 10.1056/nejmoa043330
2.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Year: 2009Citations: 7605DOI: 10.1016/s1470-2045(09)70025-7
3.
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Year: 2005Citations: 7001DOI: 10.1056/nejmoa043331
4.
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Year: 2017Citations: 2372DOI: 10.1001/jama.2017.18718
5.
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Year: 2011Citations: 1776DOI: 10.1038/nature10491
6.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Year: 2020Citations: 1667DOI: 10.1038/s41571-020-00447-z
7.
Current state of immunotherapy for glioblastoma
Year: 2018Citations: 1318DOI: 10.1038/s41571-018-0003-5
8.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
Year: 2020Citations: 1314DOI: 10.1001/jamaoncol.2020.1024
9.
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Year: 2009Citations: 1134DOI: 10.1007/s00401-009-0561-9
10.
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Year: 2012Citations: 1094DOI: 10.1016/s1470-2045(12)70164-x

About Michael Weller

Michael Weller is a researcher with 2820 publications and 160156 citations. They are affiliated with Princess Margaret Cancer Centre. Their research focuses on . With an h-index of 173, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Michael Weller and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year